Switch View
© BusinessWire
05.11.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced that Chie...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 1,185 shares of t...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US98401F1057
Xencor Inc
XNCR
LISTED
NASDAQ
Xencor Reports Third Quarter 2025 Financial Results
News Preview
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the third quarter ended September 30, 2025 and provided recent business and clinical program updates.
“Xencor’s two novel, first-in-class, CD3 T-cell enga...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
05.11.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced its financial results for the third quarter end...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
05.11.2025
ISIN: US2681582019
Dynavax Technologies Corp
DVAX
LISTED
NASDAQ
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
News Preview
Collaboration positioned to leverage Vaxart's oral vaccine platform and Dynavax's commercial experience to address the long-term need for easily administered COVID-19 vaccine options
Vaxart to continue leading and funding development...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US98160J1088
MariMed Inc.
MRMD
LISTED
CSE
MariMed Reports Third Quarter 2025 Earnings
News Preview
MariMed reports third quarter 2025 financial results...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US03940C1009
Arcellx Inc
ACLX
LISTED
NASDAQ
Arcellx Provides Third Quarter 2025 Financial Results
News Preview
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today reported financial results for the third quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights
Cash, cash equivalents, and marketable...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
EXTENDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lantheus Holdings, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - LNTH
News Preview
SAN DIEGO, Nov. 5, 2025 /PRNewswire/ --Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Lantheus Holdings, Inc. (NASDAQ: LNTH) common stock between November 6, 2024 and August 6, 2025, inclusive (the "Class Period"). Captioned Indiana Publi...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: IE00BFY8C754
STERIS plc
STE
LISTED
NYSE
STERIS Announces Financial Results for Fiscal 2026 Second Quarter
News Preview
DUBLIN, IRELAND , Nov. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 second quarter ended September 30, 2025. Total revenue from continuing operations for the second quarter of fiscal 2026 increased 10% to $1.5 billion compared with $1.3 billion in the second...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk Wegovy® users achieved waist and BMI targets linked to improved health and low risk of obesity-related complications
News Preview
Novo Nordisk presented new findings from the STEP UP phase 3b trial. It showed that, in addition to losing an average of 21% of their body weight......
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US36870H1032
Genelux Corp
GNLX
LISTED
NASDAQ
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
News Preview
-- Lung cancer programs progressing with interim data updates expected in Q4 2025 -- -- Topline data from OnPrime Phase 3 ovarian cancer registrational trial expected in the second half of 2026 --...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US70805E1091
Pennant Group Inc
PNTG
LISTED
NASDAQ
The Pennant Group Announces Expansion of Credit Facility
News Preview
The Pennant Group Announces Expansion of Credit Facility...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
05.11.2025
ISIN: US26818M1080
Dyne Therapeutics Inc
DYN
LISTED
NASDAQ
Dyne Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
News Preview
- Topline data from Registrational Expansion Cohort of DELIVER trial of zeleciment rostudirsen (z-rostudirsen, also known as DYNE-251) in DMD on track for December 2025 to support potential submission for U.S. Accelerated Approval in Q2 2026 -...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US14888U1016
Catalyst Pharmaceuticals Inc
CPRX
LISTED
NASDAQ
Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Reported Q3 2025 Total Revenues of $148.4 Million, Driven by Continued FIRDAPSE® Growth, Strong AGAMREE® Uptake and Growth, and Continued Demand for FYCOMPA®...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek Biosciences Reports Third Quarter 2025 Financial Results
News Preview
FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US1266381052
CVRx Inc
CVRX
LISTED
NASDAQ
CVRx Reports Third Quarter 2025 Financial and Operating Results
News Preview
MINNEAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the third quarter of 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US37148K1007
Generation Bio Co
GBIO
LISTED
NASDAQ
Generation Bio Announces Third Quarter 2025 Financial Results
News Preview
CAMBRIDGE, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company, today reported third quarter financial results....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US4884452065
Zevra Therapeutics Inc
ZVRA
LISTED
NASDAQ
Zevra Reports Third Quarter 2025 Financial Results and Corporate Update
News Preview
2025 EPS of $(0.01)...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US28531P1030
electroCore, Inc.
ECOR
LISTED
NASDAQ
electroCore Announces Third Quarter 2025 Financial Results
News Preview
Net sales of $8.7 million increased 33% vs. Q3 2024; YTD net sales of $22.8 million increased 26% vs. first nine months of 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US8693671021
Sutro Biopharma Inc
STRO
LISTED
NASDAQ
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
News Preview
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it will host a virtual Research & Development Day, highlighting the details of its platform innovation a...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb Prices €5 Billion of Senior Unsecured Notes
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced that it has priced a public offering (the “Offering”) of senior unsecured notes in a combined aggregate principal amount of €5 billion (collectively, the “Notes”). The Notes will be issued by Bristol Myers Squibb’s wholly-owned subsidiary, BMS Ireland Capital Funding Designated Activity Company, in...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID
News Preview
WARREN, N.J., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced a clinical milestone in the evolution of its proprietary ExacTcell™ platform: completion of T cell target identification for an additional five human leukocyte antigen (HLA) restrictions. This advancement significantl...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Law Offices of Frank R. Cruz Encourages Avantor, Inc. (AVTR) Shareholders To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”). Avantor investors have until December 29, 2025 to file a lead plaintiff motion...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Limited Announces Results for Q2 and H1 FY26
News Preview
MUMBAI, India, Nov. 5, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Limited Announces Results for Q2 and H1 FY26
News Preview
MUMBAI, India, Nov. 5, 2025 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2025....
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma
News Preview
SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma
Andreas Reisse to retire as CEO of SCHOTT Pharma as planned
Christian Mias, Executive Vice President of SCHOTT’s Electronic Packaging Business Unit, appointed as new CEO of SCHOTT Pharma effective May 1st, 2026
Seamless leadership transition ensured
The Supervisory ......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
Christian Mias wird Nachfolger von Andreas Reisse als CEO von SCHOTT Pharma
News Preview
SCHOTT Pharma: Christian Mias wird Nachfolger von Andreas Reisse als CEO von SCHOTT Pharma
Andreas Reisse tritt wie geplant als CEO von SCHOTT Pharma in den Ruhestand
Christian Mias, derzeit Executive Vice President der Business Unit Electronic Packaging bei SCHOTT, wird zum 1. Mai 2026 zum neuen CEO von SCHOTT Pharma ernannt
Eine nahtlose Überg......
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Law Offices of Howard G. Smith Encourages Avantor, Inc. (AVTR) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”). Avantor investors have until December 29, 2025 to file a lead plaintiff motion.
IF...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London
News Preview
Media ReleaseCOPENHAGEN, Denmark; November 5, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan Van de Winkel and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Jefferies Global Healthcare Conference in London at 12:00 PM GMT (7:00 AM EST) on November 19, 2025. A webcast of the fir...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
Christian Mias wird Nachfolger von Andreas Reisse als CEO
News Preview
Der Aufsichtsrat der SCHOTT Pharma Management AG hat heute Dr. Christian Mias mit Wirkung zum 1. Mai 2026 zum neuen Chief Executive Officer (CEO) von SCHOTT Pharma bestellt. Er folgt auf Andreas Reisse, der planmäßig Ende April 2026 in den Ruhestand gehen wird. Dr. Christian Mias ist seit 2007 in verschiedenen Führungspositionen innerhalb der SCHOT......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
Christian Mias to succeed Andreas Reisse as CEO
News Preview
The Supervisory Board of SCHOTT Pharma Management AG has today appointed Christian Mias as the new Chief Executive Officer (CEO) of SCHOTT Pharma, effective May 1, 2026. He will succeed Andreas Reisse, who will retire as planned at the end of April 2026. Christian Mias has held various management positions within the SCHOTT Group since 2007, most r......
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1404752032
Sonida Senior Living Inc
SNDA
LISTED
NYSE
SNDA Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Sonida Senior Living, Inc. is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Sonida Senior Living, Inc. (NYSE: SNDA) and CNL Healthcare Properties, Inc. is fair to Sonida shareholders. Upon completion of the proposed transaction, Sonida existing shareholders’ ownership would range from 39.5% to 50.0% of the newly combined company’s dilute...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Sobi to present New One-Year Data on pegcetacoplan's efficacy in C3G and primary IC-MPGN and new outcome data on NASP at ASN Kidney Week
News Preview
STOCKHOLM, Nov. 5, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that data on Aspaveli/Empaveli in C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) and NASP in uncontrolled gout will be presented at ASN Kidney Week 2025, 5-9 November in Houston, Texas....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.11.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
News Preview
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / November 5, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it will participate in the following investor conferences:2025 UBS Global Healthcare Conference -...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: FR0012882389
Equasens
EQS
LISTED
EURONEXT
Equasens: Q3 2025 revenue
News Preview
Revenue at 30 September 2025: €172.2m
+8.9% on a reported basis and +7.3% like-for-like...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US0067391062
Addus Homecare Corp
ADUS
LISTED
NASDAQ
Addus HomeCare to Participate in Upcoming Investor Conferences in November
News Preview
Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in November:
2025 UBS Global Healthcare Conference in Palm Beach Gardens, Florida. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US2036681086
Community Health Systems Inc
CYH
LISTED
NYSE
Community Health Systems Announces Participation in the 2025 UBS Global Healthcare Conference
News Preview
Community Health Systems, Inc. (NYSE:CYH) today announced that management will participate in a fireside chat at the UBS Global Healthcare Conference to be held November 10 - 12, 2025.
The fireside chat presentation will begin at 9:30 a.m. Eastern time, 8:30 a.m. Central time, on Tuesday, November 11, and will be available to investors via a live...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: AU0000054942
Imricor Medical Systems Inc.
IMR
LISTED
ASX
First in Human Ischemic VT Ablation Successfully Performed in iCMR
News Preview
Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam UMC), is pleased to announce the successful completion of the first Ischemic Ventricular Tachycardia (VT) ablation ever performed under real-time MRI guidance in an iCMR lab.
This press release features multimedia. View the f...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.11.2025
ISIN: CA92663R1055
Viemed Healthcare Inc
VMD
LISTED
NASDAQ
Viemed Healthcare Announces Third Quarter 2025 Financial Results
News Preview
LAFAYETTE, LA / ACCESS Newswire / November 5, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today that it has reported its financial results for the three and nine months ended...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US29350E2037
Lunai Bioworks Inc.
LNAI
LISTED
NASDAQ
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
News Preview
Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines".
LOS ANGELES, Nov. 5, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthroug...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
News Preview
SALT LAKE CITY, Nov. 5, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a patented platform for developing advanced molecular diagnostic tests, today announced that it has engaged Maxim Group LLC ("Maxim") as its exclusive financial advisor...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US53228F1012
LifeStance Health Group Inc
LFST
LISTED
NASDAQ
Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season
News Preview
LifeStance Survey Reveals How the Holidays Affect Mental Health, with Stress and Social Pressure Hitting Millennials and Gen Z Hardest
SCOTTSDALE, Ariz., Nov. 5, 2025 /PRNewswire/ -- Findings from a LifeStance Health survey released today reveal that for many Am...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
News Preview
Completion of key step in IND transfer for upcoming Phase 2 breast cancer vaccine clinical trial
SAN JOSE, Calif., Nov. 5, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment an...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025. The meeting is taking place November 5 - 9 at the Gaylord National Convention Center in National...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare Announces $1.5 Million HCA Healthcare Foundation Grant to Support March of Dimes' Low Dose, Big Benefits™ Campaign
News Preview
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the HCA Healthcare Foundation, through its Healthier Tomorrow Fund, will strengthen its collaboration with March of Dimes, a leading nonprofit fighting for the health of all moms and babies, through a new $1.5 million grant to support their Low Dose,...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes
News Preview
New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by short-read sequencing technologies, positioning HiFi as the bridge between research and clinical-grade genomics New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by shor...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: KR7302440003
SK Bioscience Co Ltd
302440
LISTED
KOE
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025
News Preview
Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune therapeutics
Strengthening global CDMO strategy through strategic synergy with SK bioscience...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Quebec Expands Public Funding for CAPVAXIVE®
News Preview
KIRKLAND, QC, Nov. 5, 2025 /CNW/ -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the province of Quebec has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to their publicly funded adult immunization program. This addition makes the vaccine available...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
News Preview
SOUTH JORDAN, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive findings from the randomized AVF arm of the WAVE trial. These findings were presented during the Late-Breaking Clinical Trials session on Tuesday, November 4, 2025, at the Vascular In...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: KR7009290008
Kwang Dong Pharmaceutical Co., Ltd.
009290
LISTED
KOE
Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia to the MFDS in South Korea
News Preview
Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that its partner, Zhaoke Ophthalmology Ltd. (“Zhaoke Ophthalmology”), a leading ophthalmic pharmaceutical company, has supported its South Korean partner, Kwangdong Pha...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs Reports Third Quarter 2025 Financial Results
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2025.
Third Quarter Highlights and Outlook (Unaudited)
Third quarter worldwide r...
Themefolio
Profiler
Peergroup
© Newsfile
05.11.2025
ISIN: CA14161Y2006
Cardiol Therapeutics Inc
CRDL
LISTED
TSX
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
News Preview
The ESC M&PD meeting brings together the world's experts working to improve the treatment of myocarditis and pericarditis.Presentation to provide comprehensive findings from the ARCHER trial following the reporting of topline results demonstrating a notable improvement in extracellular volume and a significant reduction in left ventricular mass...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: CA45074T1021
Ianthus Capital Holdings Inc.
IAN
LISTED
CSE
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers
News Preview
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
News Preview
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S....
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US45780L1044
Inogen Inc
INGN
LISTED
NASDAQ
Inogen Announces Third Quarter 2025 Financial Results
News Preview
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2025.
Recent Highlights
$92.4 million revenue, a year-over-year increase of 4.0%, marking the seventh consecutive quarter of mid-single-digit pe...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1404752032
Sonida Senior Living Inc
SNDA
LISTED
NYSE
Sonida Senior Living Announces Strategic Merger with CNL Healthcare Properties, Inc. in a Stock and Cash Transaction Valued at Approximately $1.8 Billion, Creating $3 Billion Pure-Play Senior Housing Owner-Operator
News Preview
Sonida Senior Living, Inc. (“Sonida” or the “Company”) (NYSE: SNDA), a leading owner, operator and investor in senior living communities, and CNL Healthcare Properties, Inc. (“CHP”), a public non-traded real estate investment trust (“REIT”) which owns a national portfolio of high-quality senior housing communities, today announced a definitive mer...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
News Preview
MaxCyte will now host its earnings conference call on November 12, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US92790C1045
Viridian Therapeutics Inc
VRDN
LISTED
NASDAQ
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
News Preview
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today reported recent business highlights and financial results for the third quarter ended September 30, 2025.
“The Viridian team continues to deliver stron...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed to Participate in Upcoming Investor Conferences
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:
Stifel 2025 Healthcare Conference
Fo...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Laboratories Provides Update on Strategic Review
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) today announced an update on its Board of Directors’ comprehensive strategic review of the Company’s business and growth prospects. The Board strongly supports the Company’s strategic direction and believes it should continue to focus on strengthening its leading scientific portfolio withi...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
